| Biotechnology Industry | Healthcare Sector | Howard J. Verrico CEO | XDUS Exchange | CA82967M1005 ISIN |
| CA Country | 10 Employees | - Last Dividend | - Last Split | - IPO Date |
Sirona Biochem Corp. is a pioneering entity in the cosmetic and pharmaceutical fields, focusing on the development and commercialization of innovative active ingredients. Based in Vancouver, Canada, and extending its operations to France, the company is dedicated to creating advanced solutions that span across cosmetic skin lightening, diabetes management, anti-aging treatments, and anti-viral therapies. Initially founded in 2006 as High Rider Capital Inc., it underwent a significant rebranding to Sirona Biochem Corp. in May 2009. Through strategic research collaboration agreements, notably with the International Centre for Genetic Engineering and Biotechnology (ICGEB), Sirona Biochem is at the forefront of developing antiviral compounds, showcasing its commitment to addressing global health challenges.
This offering involves the development of safe and effective skin lightening ingredients designed for the cosmetic industry. These products are tailored to meet the growing demand for skin care solutions that can help in achieving a more balanced and radiant skin tone, leveraging scientifically-backed formulations to ensure both efficacy and safety for users.
Sirona Biochem is involved in the discovery and development of novel therapeutic agents aimed at managing diabetes. This initiative reflects the company’s dedication to addressing the global diabetes epidemic through innovation, by focusing on creating drugs that can offer improved outcomes for patients living with this challenging condition.
The development of an anti-aging and cell protection library signifies Sirona Biochem's engagement in creating a comprehensive range of compounds designed to combat the signs of aging and protect the skin at the cellular level. This project aims at offering revolutionary products that can slow down the aging process, ensuring healthier and younger-looking skin.
This initiative focuses on the formulation of a unique compound targeting the reduction of wrinkles, signifying the company’s commitment to advancing skincare solutions. Through cutting-edge research, Sirona Biochem seeks to offer innovative products that address the needs of consumers aiming for a smoother and more youthful appearance.
In collaboration with the International Centre for Genetic Engineering and Biotechnology (ICGEB), Sirona Biochem is dedicated to the development of an antiviral library of compounds. This program highlights the company’s proactive approach in contributing to the global fight against viral diseases, showcasing its capability to innovate in the realm of therapeutic solutions.